|
|
 |
Publications
Displaying 861 through 880 of 1537 items.
« Previous
Page
1 10 20 30 40 41 42 43
44
45 46 47 48 49 50 60 70 77
Next »
[Show All]
| 2005 |
Moorman, P.G., J.M. Schildkraut, B. Calingaert, S. Halabi, and A. Berchuck. (2005). "Menopausal hormones and risk of ovarian cancer." American Journal of Obstetrics and Gynecology, 193(1):75-82.
Objective
The objective of this study was to determine if use of menopausal hormones was associated with ovarian cancer and if risk varied by type of hormone used.
Study design
Data from a...
Full Abstract »
|
Santanello, N., J. Norquist, L. Nelsen, V. Williams, C.D. Hill, and H. Bisgaard. (2005). "Validation of a pediatric caregiver diary to measure symptoms of postacute respiratory syncytial virus bronchiolitis." Pediatric Pulmonology, 40(1):31-38.
Acute respiratory syncytial virus (RSV)-induced bronchiolitis is often associated with continuing respiratory symptoms following hospitalization. To date, there is no validated objective measure to...
Full Abstract »
|
Cragun, J.M., L.J. Havrilesky, B. Calingaert, I. Synan, A.A. Secord, J.T. Soper, D.L. Clarke-Pearson, and A. Berchuck. (2005). "Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer." Journal of Clinical Oncology, 23(16):3668-3675.
PURPOSE: Selective lymphadenectomy is widely accepted in the management of endometrial cancer. Purported benefits are individualization of adjuvant therapy based on extent of disease and resection...
Full Abstract »
|
Irish, W., B. Sherrill, B. Cole, C. Gard, G.A. Glendenning, and H. Mouridsen. (2005). "Quality-Adjusted Survival in a Crossover Trial of Letrozole Versus Tamoxifen in Postmenopausal Women with Advanced Breast Cancer." Annals of Oncology.
Background: Results from a phase III study of postmenopausal women with advanced breast cancer demonstrated longer time to disease progression for patients taking letrozole versus tamoxifen. This...
Full Abstract »
|
Mauskopf, J.A., S.R. Earnshaw, and C. Mullins. (2005). "Budget impact analysis: review of the state of the art." Expert Review of Pharmacoeconomics & Outcomes Research, 5(1):65-79.
A budget impact analysis for a new pharmaceutical product provides estimates of the likely impact of the new drug on a healthcare decision makers short- and longer-term annual budgets. Budget...
Full Abstract »
|
Cella, D., R.S. Herbst, T.J. Lynch, D. Prager, C.P. Belani, J.H. Schiller, A. Heyes, J.S. Ochs, M.K. Wolf, A.C. Kay, M.G. Kris, and R.B. Natale. (2005). "Clinically meaningful improvement in symptoms and quality of life for patients with non-small-cell lung cancer receiving gefitinib in a randomized controlled trial." Journal of Clinical Oncology, 23(13):2946-2954.
PURPOSE: Evaluation of disease-related symptom improvement rate by the Lung Cancer Subscale (LCS) of the Functional Assessment of Cancer Therapy-Lung (FACT-L) questionnaire was a coprimary end point...
Full Abstract »
|
Spillman, M.A., J.M. Schildkraut, S. Halabi, P. Moorman, B. Calingaert, R.C. Bentley, J.R. Marks, S. Murphy, and A. Berchuck. (2005). "Transforming growth factor ? receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk." Gynecologic Oncology, 97(2):543-549.
Objectives
It has been suggested that the 6A allele of the type I TGF? receptor (TGF?R1) polyalanine repeat tract polymorphism may increase susceptibility to various types of cancer including...
Full Abstract »
|
Mockenhaupt, M., J. Messenheimer, P. Tennis, and J. Schlingmann. (2005). "Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics." Neurology, 64(7):1134-8.
BACKGROUND: Estimates of risk of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) associated with some antiepileptic drugs (AEDs) have used denominators based on the number of...
Full Abstract »
|
Moorman, P.G., A. Berchuck, B. Calingaert, S. Halabi, and J.M. Schildkraut. (2005). "Antidepressant medication use for and risk of ovarian cancer." Obstetrics and Gynecology, 105(4):725-730.
OBJECTIVE: It has been hypothesized that antidepressants may enhance cancer growth. Previous studies of antidepressant use and ovarian cancer have been inconsistent and have been limited in their...
Full Abstract »
|
Mauskopf, J.A., C. Paramore, W.C. Lee, and E.H. Snyder. (2005). "Drug persistency patterns for patients treated with rivastigmine or donepezil in usual care settings." Journal of Managed Care Pharmacy, 11(3):231-51.
OBJECTIVE: To compare levels of persistency with 2 cholinesterase (ChE) inhibitors-rivastigmine and donepezil for the treatment of Alzheimer's disease (AD) through the use of administrative claims...
Full Abstract »
|
Yost, K.J., S.E. Yount, D.T. Eton, C. Silberman, A. Broughton-Heyes, and D. Cella. (2005). "Validation of the Functional assessment of cancer therapy-Breast Symptom Index (FBSI)." Breast Cancer Research and Treatment, 90(3):295-298.
We assessed the reliability, validity, and responsiveness to change of the 6-item Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI) in a sample of 615 metastatic breast cancer...
Full Abstract »
|
Greenhalgh, J., C.J. Knight, D. Hind, C. Beverley, and S. Walters. (2005). "Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies." Health Technology Assessment, 9(9):1-170.
OBJECTIVES: To establish the clinical effectiveness and cost-effectiveness of electroconvulsive therapy (ECT) for depressive illness, schizophrenia, catatonia and mania. DATA SOURCES: Electronic...
Full Abstract »
|
Beach, R.H., S.K. Pattanayak, J.C. Yang, B.C. Murray, and R.C. Abt. (2005). "Econometric Studies of Non-Industrial Private Forest Management: A Review and Synthesis." Forest Policy and Economics, 7(3):261-281.
Forest policies and management increasingly rely on economic models to explain behaviors of landowners and to project forest outputs, inventories and land use. However, it is unclear whether the...
Full Abstract »
|
Cunnington, M.L., and P.S. Tennis. (2005). "Lamotrigine and the risk of malformations in pregnancy." Neurology, 64:955-960.
Objective: To report the frequency of major malformations in lamotrigine-exposed pregnancies from September1, 1992, through March 31, 2004, in the International Lamotrigine Pregnancy Registry....
Full Abstract »
|
Huerta, C., J. Castellsague, C. Varas-Lorenzo, and L.A. Garcia Rodriguez. (2005). "Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population." American Journal of Kidney Diseases, 45(3):531-539.
Background: Most epidemiological studies evaluating the association between nonsteroidal anti-inflammatory drugs (NSAIDs) and acute renal failure (ARF) found an increased risk for developing ARF...
Full Abstract »
|
Richter, A., M. Pladevall, R. Manjunath, J.E. Lafata, H. Xi, J. Simpkins, I. Brar, N. Markowitz, U. Iloeje, and W. Irish. (2005). "Patient characteristics and costs associated with dyslipidaemia and related conditions in HIV-infected patients: a retrospective cohort study." HIV Medicine, 6(2):79-90.
Background: Metabolic abnormalities are common in HIV-infected individuals and, although multifactorial in origin, have been strongly associated with antiretroviral therapy. Methods: Using...
Full Abstract »
|
Legendre, C., S.M. Beard, A. Crochard, Y. Lebranchu, C. Pouteil-Noble, A. Richter, and I. Durand-Zaleski. (2005). "The cost-effectiveness of prophylaxis with valaciclovir in the management of cytomegalovirus after renal transplantation." European Journal of Health Economics, 6(2):172-182.
Abstract: Prophylaxis-based antiviral treatment and intensive monitoring followed by pre-emptive antiviral treatment are both commonly used management strategies to reduce risk of cytomegalovirus...
Full Abstract »
|
Wenzel, R., A. Del Favero, C. Kibbler, T. Rogers, C. Rotstein, J. Mauskopf, S. Morris, H. Schlamm, P. Troke, and A. Marciniak. (2005). "Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients." Journal of Antimicrobial Chemotherapy, 55(3):352-361.
Objective: The objective of this study was to conduct an economic evaluation of voriconazole compared with conventional amphotericin B deoxycholate (CAB) using data from a recently reported...
Full Abstract »
|
Gregson, N.N., K.K. Sparrowhawk, J.A. Mauskopf, and J.E. Paul. (2005). "Pricing Medicines: Theory and Practice, Challenges and Opportunities." Nature Reviews Drug Discovery, 4:121-130.
The pricing of medicines has become one of the most hotly debated topics of recent times, with the pharmaceutical industry seemingly being attacked from all quarters. From a company perspective,...
Full Abstract »
|
Brogan, A.J., and S. Stidham. (2005). "A note on separation in mean-lower-partial-moment portfolio optimization with fixed and moving targets." IIE Transactions, 37(10):901-906.
As measures of portfolio risk, Lower Partial Moments (LPMs) have several advantages over variance, the traditional measure of risk. A separation theorem can be proven in the context of mean-LPM...
Full Abstract »
|
Displaying 861 through 880 of 1537 items.
« Previous
Page
1 10 20 30 40 41 42 43
44
45 46 47 48 49 50 60 70 77
Next »
[Show All]
|